AliveCor Logo

Unsere Produkte

Kardia 12L

Neu

KardiaMobile 6L
InstantQT
KardiaPro
Kardia EKG-Geräte

Unsere Lösungen

AF-Screening
Datenintegrationslösungen
Gesundheitsdienstleister
BioPharma

Um

Führung
Mission
Klinische Forschung
Newsroom
Shop all Products
Resource Hub
Contact Us
AliveCor Logo
AliveCor Logo
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • (855) 338-8800
    • Mission
    • Führung
    • Forschung
    • Karrieren
    • Nachrichtenredaktion
    • Ressourcen-Hub
    • FAQs
    • Benutzerhandbücher
    • Versand
    • Garantie
    • Wiederverkäufer
    • Integration
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaCare
    • International
    • CO2-Reduktionsplan
    • Erklärung zur modernen Sklaverei
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Datenschutzrichtlinie
  • Sicherheit
  • Einverständniserklärung zur Telemedizin
  • Bedingungen
  • Zugänglichkeit

©2024 AliveCor, Inc. Alle Rechte vorbehalten.

Nachrichtenredaktion

Durchsuchen Sie die neuesten Informationen von AliveCor

Auszeichnungen

Digital Health Awards Spring 2026

Artikel lesen

Digital Health Awards Spring 2024

Artikel lesen

Digital Health Awards Spring 2022

Artikel lesen

TIME World's Top HealthTech Companies of 2025

Artikel lesen

Edison Awards 2025

Artikel lesen

Inc. Magazine's 2024 Best in Business Award Winner

Artikel lesen

New York Product Design Awards 2024

Artikel lesen

Fierce Healthcare Innovation Awards 2022

Artikel lesen

Medtech Breakthrough Awards for Best New Technology Solution 2023

Artikel lesen

Fast Company's World Changing Ideas Award 2023

Artikel lesen

Inc. 2023 Best in Business Honoree

Artikel lesen

Nach Jahr filtern

Für alle Presseanfragen wenden Sie sich bitte an press@alivecor.com

Most Recent

7. Mai 2026

Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk

Artikel lesen

27. April 2026

AliveCor Expands eHealth Service to Android Users

Artikel lesen

27. April 2026

AliveCor Transforms Heart Monitor into eHealth Service

Artikel lesen

27. April 2026

AliveCor Launches AI-Powered Kardia 12L in Europe: The World's First Handheld 12-Lead ECG with a Unique Single-Cable Design

Artikel lesen

27. April 2026

AliveCor’s Kardia 12L ECG System Awarded Inc.’s 2024 Best in Business Awards

Artikel lesen

27. April 2026

ALIVECOR RECEIVES FDA OVER-THE-COUNTER CLEARANCE FOR ITS HEART MONITOR

Artikel lesen

27. April 2026

ALIVECOR EXPERT ECG ANALYSIS SERVICE NOW AVAILABLE IN UK AND IRELAND

Artikel lesen

27. April 2026

AliveCor Continues To Improve Its Service Offerings

Artikel lesen

27. April 2026

AliveCor Appoints Clyde Hosein as Chief Financial Officer

Artikel lesen

27. April 2026

AliveCor Files ITC Complaint Seeking to Bar U.S. Importation of Apple Watch

Artikel lesen

27. April 2026

Hannover Medical School pioneers integration of GE HealthCare and AliveCor technologies to enhance cardiac care

Artikel lesen

27. April 2026

Kardia 12L ECG System Receives CMS Reimbursement Approval

Artikel lesen

27. April 2026

AliveCor Offers Integration With Practice Fusion's Electronic Health Records Platform

Artikel lesen

27. April 2026

AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device

Artikel lesen

27. April 2026

AliveCor Launches New App to Auto Detect Atrial Fibrillation in an ECG Recording

Artikel lesen

27. April 2026

AliveCor Honored as one of FierceMedicalDevices’ Fierce 15 Most Promising Private Medical and Diagnostic Companies in the World

Artikel lesen

27. April 2026

AliveCor® to Showcase the AliveCor Heart Monitor at the American Heart

Artikel lesen

27. April 2026

Omron Healthcare and AliveCor Collaborate for Heart Health

Artikel lesen

27. April 2026

AliveCor Launches Third Generation Heart Monitor Advancing the Future of Heart Health

Artikel lesen

27. April 2026

Study Results from Cleveland Clinic’s iTransmit Study Published in

Artikel lesen

27. April 2026

AliveCor Launches Ability to Detect A Serious Heart Condition in an ECG on a Mobile Device

Artikel lesen

27. April 2026

AliveCor Announces Results of SEARCH-AF Trial

Artikel lesen

27. April 2026

Studies Presented at Heart Rhythm 2014 Demonstrate Accuracy of the AliveCor® Heart Monitor and Confirm Patient Satisfaction

Artikel lesen

27. April 2026

Free Heart Screenings Available in More than 100 Pharmacies in North East London

Artikel lesen

27. April 2026

One Million ECGs Recorded with the AliveCor® Heart Monitor

Artikel lesen

27. April 2026

AliveCor’s KardiaMobile Card Awarded Fast Company’s 2023 World Changing Ideas Awards and 2023 MedTech Breakthrough Awards

Artikel lesen

27. April 2026

AliveCor Announces FDA Clearance for Two New Automated Detectors for Normal Recordings and Noise Interference

Artikel lesen

27. April 2026

AliveCor Launches New App that Automatically Tells Patients When Their ECG Recording is Normal

Artikel lesen

27. April 2026

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

Artikel lesen

27. April 2026

AliveCor and Preventice Solutions Launch Pilot Cloud-Based Analytics Program

Artikel lesen

27. April 2026

AliveCor Launches Third Generation Heart Monitor in the UK & Ireland

Artikel lesen

27. April 2026

AliveCor Launches Updated App that Provides New Heart Journal

Artikel lesen

27. April 2026

AliveCor Announces Availability of its Mobile ECG in Canada

Artikel lesen

27. April 2026

AliveCor Awarded as Technology Pioneer by World Economic Forum

Artikel lesen

27. April 2026

AliveCor Mobile ECG Shows Momentum as Tool for AFib Detection

Artikel lesen

27. April 2026

AliveCor Announces Appointment of Chief Executive Officer

Artikel lesen

27. April 2026

AliveCor and ILLIES Announce New Distribution Agreement in Hong Kong and Macau

Artikel lesen

27. April 2026

AliveCor Partners with LifeWatch to Expand Into Remote Patient

Artikel lesen

27. April 2026

New Kardia™ Band for Apple Watch Delivers Medical-grade Electrocardiogram (EKG) Anytime, Anywhere

Artikel lesen

27. April 2026

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales

Artikel lesen

27. April 2026

New AliveCor Leaders Further AliveCor’s Momentum in Wearable MedTech

Artikel lesen

27. April 2026

Clinical Research From HRS Validates AliveCor Delivers Value-Based Care for Heart Health

Artikel lesen

27. April 2026

AliveCor Introduces First iOS App Combining ECG and Blood Pressure to Manage Heart Health

Artikel lesen

27. April 2026

AliveCor and Mayo Clinic Announce Collaboration to Identify Hidden Health Signals in Humans

Artikel lesen

27. April 2026

AliveCor Unveils Medical Grade Mobile App to Manage Top Risk Factors for Stroke

Artikel lesen

27. April 2026

New medical grade single lead ECG on your WRIST helps discover possible Atrial Fibrillation, a leading cause of stroke in the UK

Artikel lesen

27. April 2026

Launch of world’s smallest single lead ECG

Artikel lesen

27. April 2026

AliveCor Named to Fast Company's Top 10 Most Innovative Companies in Health

Artikel lesen

27. April 2026

AliveCor Unveils First AI-Enabled Platform for Doctors to Improve Stroke Prevention Through Early Atrial Fibrillation Detection

Artikel lesen

27. April 2026

AI That Sees the Invisible: AliveCor and Mayo Clinic Announce Collaboration to Develop Groundbreaking AI Technology to Help Prevent Sudden Cardiac Death

Artikel lesen

27. April 2026

AliveCor Appoints Michael Rolla as Chief Revenue Officer, Enterprise

Artikel lesen

27. April 2026

New Research Confirms Significance of AliveCor’s 30 Second EKG

Artikel lesen

27. April 2026

FDA Clears First Medical Device Accessory for Apple Watch®

Artikel lesen

27. April 2026

AliveCor Granted Patent for Proactive Notification of Possible Heart Arrhythmias

Artikel lesen

27. April 2026

AliveCor Named No.1 Artificial Intelligence Company in Fast Company’s 2018 Most Innovative Companies Ranking

Artikel lesen

27. April 2026

Cleveland Clinic Study Affirms Accurate Detection of Atrial Fibrillation by KardiaBand for Apple Watch

Artikel lesen

27. April 2026

AliveCor Data Yield Reaches 25MM ECGs Largest Data Set of Any Consumer ECG Device

Artikel lesen

27. April 2026

Previously Invisible Long QT Syndrome Now Observable With Machine Learning

Artikel lesen

27. April 2026

FDA Designates AliveCor’s Bloodless Hyperkalemia Test a “Breakthrough Device.”

Artikel lesen

27. April 2026

AliveCor AI Found to Compare Favorably to Surgically Implanted Loop Recorder

Artikel lesen

27. April 2026

AliveCor's Mobile ECG Technology Could Enable More Rapid Diagnosis and Treatment of Heart Attacks

Artikel lesen

27. April 2026

AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association

Artikel lesen

27. April 2026

AliveCor Appoints Dr. Jacqueline Shreibati, Chief Medical Officer

Artikel lesen

27. April 2026

Three New Studies Confirm Clinical Utility of AliveCor's KardiaMobile Device and AI Algorithms

Artikel lesen

27. April 2026

New AliveCor Partnership Marks Expansion into Chinese Heart Health Market

Artikel lesen

27. April 2026

FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device

Artikel lesen

27. April 2026

FDA Grants First Ever Clearance For Six-Lead Personal ECG Device

Artikel lesen

27. April 2026

AliveCor Appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board

Artikel lesen

27. April 2026

Olympic Icon Mark Spitz Partners with AliveCor To Build Awareness Around Heart Health

Artikel lesen

27. April 2026

AliveCor and Huami Partner To Deliver The Next Generation of Medical Wearables

Artikel lesen

27. April 2026

AliveCor Receives Approval to Launch KardiaMobile in Mexico

Artikel lesen

27. April 2026

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients

Artikel lesen

27. April 2026

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

Artikel lesen

27. April 2026

AliveCor to Provide QTc Measurement for Clinicians Treating COVID-19 Patients

Artikel lesen

27. April 2026

AliveCor and OMRON Announce Global Strategic Alliance for Comprehensive Remote Cardiovascular Monitoring

Artikel lesen

27. April 2026

AliveCor Partners with The Clifford Lab at Emory University and Georgia Institute of Technology

Artikel lesen

27. April 2026

AliveCor Expands Telemedicine Services to Support Heart Care at Home

Artikel lesen

27. April 2026

AliveCor Brings World's Only Six-lead, FDA-cleared Personal ECG to India

Artikel lesen

27. April 2026

AliveCor Appoints Toby Cosgrove, M.D. to Board of Directors

Artikel lesen

27. April 2026

AliveCor Closes $65 Million Financing to Accelerate Growth of Its Remote Cardiology Platform For Consumers, Employers, and Providers

Artikel lesen

27. April 2026

FDA Clears First of its Kind Algorithm Suite for Personal ECG

Artikel lesen

27. April 2026

AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG

Artikel lesen

27. April 2026

Introduction of AliveCor's revolutionary InstantQT® solution set to streamline ECG evaluation and enhance patient safety across Europe

Artikel lesen

27. April 2026

ITC Formally Commences Investigation into Apple Watch Infringement of AliveCor Patents

Artikel lesen

27. April 2026

Apple Abused Market Power in Cardio Device Market, Suit Alleges

Artikel lesen

27. April 2026

AliveCor Acquires CardioLabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services

Artikel lesen

27. April 2026

FDA Clears Personal ECG Device for Measurement of QTc Interval, a Critical Marker for Patient Safety

Artikel lesen

27. April 2026

New Study Demonstrates KardiaMobile 6L Reduces Urgent Healthcare Utilization

Artikel lesen

27. April 2026

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

Artikel lesen

27. April 2026

KardiaMobile 6L is Superior to One Lead Personal Devices

Artikel lesen

27. April 2026

AliveCor Launches AliveCor Labs

Artikel lesen

27. April 2026

AliveCor’s Kardia 12L ECG System Receives Category III CPT Codes

Artikel lesen

27. April 2026

AliveCor Lists its Industry-leading KardiaMobile 6L in Epic's App Orchard Marketplace

Artikel lesen

27. April 2026

AliveCor Announces Strategic Additions to Executive Team

Artikel lesen

27. April 2026

FDA Clears World’s First Credit-Card-Sized Personal ECG

Artikel lesen

27. April 2026

ALIVECOR APPOINTS PATRICIA BARAN TO SERVE AS SENIOR VICE PRESIDENT, HEALTHCARE AMERICAS

Artikel lesen

27. April 2026

AliveCor Launches KardiaComplete to Help Reduce the Rising Health and Economic Costs of Heart Disease

Artikel lesen

27. April 2026

ITC Administrative Law Judge Finds Apple Infringed AliveCor’s Patented Technology

Artikel lesen

27. April 2026

AliveCor Announces Series F Financing to Help Expand Offerings to Key Healthcare Industry Stakeholders

Artikel lesen

27. April 2026

AliveCor's KardiaMobile Card Honored by the 2022 Fierce Life Sciences Innovation Awards and the 2023 CES® Innovation Awards

Artikel lesen

27. April 2026

AliveCor Raises $10.5M in Series B Financing

Artikel lesen

27. April 2026

ITC Rules Apple Violated AliveCor’s Patents

Artikel lesen

27. April 2026

AliveCor Delivers Breakthrough Mobile ECG Device for Veterinarians

Artikel lesen

27. April 2026

Study Points to Mobile Device as Breakthrough for Community Screening and Stroke Prevention

Artikel lesen

27. April 2026

AliveCor’s Heart Monitor for iPhone Receives FDA Clearance

Artikel lesen

27. April 2026

AliveCor Expands Mobile ECG Device Offering to Include iPhone 5

Artikel lesen

27. April 2026

AliveCor Supports UCSF’s Online Health eHeart Study

Artikel lesen

27. April 2026

AliveCor Announces the ITC's Limited Exclusion Order Against Apple Clears Presidential Review

Artikel lesen

27. April 2026

Former Lions and Wales Rugby Captain Alun Wyn Jones partners with AliveCor to launch ‘Let’s Talk Rhythm’ campaign to raise awareness of atrial fibrillation

Artikel lesen

27. April 2026

WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

Artikel lesen

27. April 2026

AliveCor Expands Mobile ECG Device Offering to United Kingdom & Ireland

Artikel lesen

27. April 2026

AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions

Artikel lesen

27. April 2026

AliveCor Launches New Feature to Enhance Visual Quality of ECG

Artikel lesen

27. April 2026

First Wireless Smartphone Electrocardiogram Demonstrates Success in Monitoring Patients’ Heart Health

Artikel lesen

27. April 2026

AliveCor Announces Smartphone Electrocardiogram Demonstrates Accuracy in Monitoring Patients’ Heart Health

Artikel lesen

27. April 2026

AliveCor Mobile ECG Device for Heart Rhythm Monitoring Now Available by Prescription

Artikel lesen

27. April 2026

U.K. Hospitals to Use New AliveCor Heart Monitor During Heart Rhythm

Artikel lesen

27. April 2026

AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

Artikel lesen

27. April 2026

Hannover Medical School pioneers integration of GE HealthCare and AliveCor technologies to enhance cardiac care

Artikel lesen

27. April 2026

AliveCor Launches First-of-its-Kind AI-Powered Kardia 12L ECG System in India

Artikel lesen

27. April 2026

AliveCor Unveils Versatile Mobile Heart Monitor

Artikel lesen

27. April 2026

AliveCor and British Heart Foundation Join Forces in a Year-Long Campaign

Artikel lesen

27. April 2026

AliveCor Launches AI-Powered KardiaMobile 6L Max and KardiaAlert to Deliver the Most Advanced Personal ECG Solution on the Market

Artikel lesen

27. April 2026

New Study Shows AliveCor's Kardia 12L ECG System Performs Equivalently to a Standard 12-Lead ECG

Artikel lesen

27. April 2026

AliveCor's Services & Solutions are Now Available to Veterans

Artikel lesen

Untersuchungszweck

Die Forschung mit dem Titel „Investigational Use“ wurde mit AliveCor-Geräten zu Forschungszwecken durchgeführt und untersucht potenzielle zukünftige Geräte und Konfigurationen.

Werden Sie Partner von AliveCor

Erfahren Sie mehr über unsere Datenintegrationslösungen.